Variant report
Variant | esv3340782 |
---|---|
Chromosome Location | chr6:86424133-86428531 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550522218 | chr6:86424845-86424846 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143147947 | chr6:86424863-86424864 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539541595 | chr6:86424871-86424872 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558257923 | chr6:86424875-86424876 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570538223 | chr6:86424887-86424888 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186568294 | chr6:86424894-86424895 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191570245 | chr6:86424928-86424929 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373149685 | chr6:86424955-86424956 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552911184 | chr6:86425030-86425031 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574735965 | chr6:86425117-86425118 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9342045 | chr6:86425148-86425149 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs147477361 | chr6:86425151-86425152 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575342055 | chr6:86425154-86425155 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545567396 | chr6:86425178-86425179 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79452758 | chr6:86425274-86425275 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545207418 | chr6:86425308-86425309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145344809 | chr6:86425310-86425311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183800255 | chr6:86425329-86425330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147852700 | chr6:86425333-86425334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186367719 | chr6:86425348-86425349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs79642582 | chr6:86425388-86425389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530841617 | chr6:86425418-86425419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569045249 | chr6:86425458-86425459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551500575 | chr6:86425482-86425483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs148468694 | chr6:86425488-86425489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567854304 | chr6:86425492-86425493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534034551 | chr6:86425530-86425531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs546730595 | chr6:86425547-86425548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568300455 | chr6:86425594-86425595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535743122 | chr6:86425614-86425615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190915653 | chr6:86425636-86425637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557328870 | chr6:86425692-86425693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34997664 | chr6:86425701-86425702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183443282 | chr6:86425794-86425795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79928818 | chr6:86425819-86425820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557472295 | chr6:86425869-86425870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142626848 | chr6:86425874-86425875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs186628470 | chr6:86425875-86425876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192715955 | chr6:86426013-86426014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573923114 | chr6:86426018-86426019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553578880 | chr6:86426065-86426066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs73485500 | chr6:86426129-86426130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562806922 | chr6:86426173-86426174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533477496 | chr6:86426188-86426189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs199785403 | chr6:86426191-86426192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs202037832 | chr6:86426275-86426276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111629903 | chr6:86426276-86426277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs60288575 | chr6:86426277-86426278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs58218011 | chr6:86426283-86426284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560292870 | chr6:86426307-86426308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abnormal development | 18461090 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:86424800-86425000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr6:86424800-86425000 | Active TSS | Skeletal Muscle Female | skeletal muscle |
3 | chr6:86425000-86425200 | Flanking Active TSS | Skeletal Muscle Female | skeletal muscle |
4 | chr6:86425200-86425600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
5 | chr6:86425200-86425600 | Enhancers | Dnd41 | blood |
6 | chr6:86425200-86437200 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |